Physician profile
Rita V Knause
NPI 1649218173
$4,481.28
in general payments reported to CMS, 2019-2025
16 companies · $3,627 in 2025
The $3,627 reported for 2025 was more than what 96% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $178 · 2020: $152 · 2021: $61.55 · 2022: $79.37 · 2023: $193 · 2024: $191 · 2025: $3,627.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,500 · Food and Beverage: $510.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,500.00 |
| Food and Beverage | $510.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $3,546.12 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $163.90 | 2019-2025 | Gardasil 9, Vaxneuvance, Gardasil |
| Glaxosmithkline, LLC. | $155.00 | 2019-2023 | Bexsero |
| Qiagen, LLC | $152.34 | 2020 | |
| Amarin Pharma, INC. | $121.84 | 2019 | |
| Sanofi Pasteur INC. | $65.50 | 2022-2025 | |
| Rgh Enterprises LLC | $54.00 | 2024 | |
| Coopersurgical, INC. | $48.14 | 2019-2024 | Paragard T 380a, Paragard T 380a |
| Exact Sciences Corporation | $47.99 | 2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Organon LLC | $41.77 | 2021-2024 | |
| Medtronic, INC. | $34.31 | 2024 | Minimed 780g |
| Gilead Sciences, INC. | $22.86 | 2024 | Epclusa |
| Bayer Healthcare Pharmaceuticals INC. | $14.27 | 2019 | |
| Phadia US INC. | $13.24 | 2023 | Immunocap |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rita Knause listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.